MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1182/blood-2011-12-398818

Медицинская библиотека · Blood · 2012

Zebrafish screen identifies novel compound with selective toxicity against leukemia.

Ridges Suzanne, Heaton Will L, Joshi Deepa, Choi Henry, Eiring Anna, Batchelor Lance, Choudhry Priya, Manos Elizabeth J, Sofla Hossein, Sanati Ali, Welborn Seth, Agarwal Archana, Spangrude Gerald J, Miles Rodney R, Cox James E, Frazer J Kimble, Deininger Michael, Balan Kaveri, Sigman Matthew, Müschen Markus, Perova Tatiana, Johnson Radia, Montpellier Bertrand, Guidos Cynthia J, Jones David A, Trede Nikolaus S

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

To detect targeted antileukemia agents we have designed a novel, high-content in vivo screen using genetically engineered, T-cell reporting zebrafish. We exploited the developmental similarities between normal and malignant T lymphoblasts to screen a small molecule library for activity against immature T cells with a simple visual readout in zebrafish larvae. After screening 26 400 molecules, we identified Lenaldekar (LDK), a compound that eliminates immature T cells in developing zebrafish without affecting the cell cycle in other cell types. LDK is well tolerated in vertebrates and induces long-term remission in adult zebrafish with cMYC-induced T-cell acute lymphoblastic leukemia (T-ALL). LDK causes dephosphorylation of members of the PI3 kinase/AKT/mTOR pathway and delays sensitive cells in late mitosis. Among human cancers, LDK selectively affects survival of hematopoietic malignancy lines and primary leukemias, including therapy-refractory B-ALL and chronic myelogenous leukemia samples, and inhibits growth of human T-ALL xenografts. This work demonstrates the utility of our method using zebrafish for antineoplastic candidate drug identification and suggests a new approach for targeted leukemia therapy. Although our efforts focused on leukemia therapy, this screening approach has broad implications as it can be translated to other cancer types involving malignant degeneration of developmentally arrested cells.

Для цитирования: Ridges Suzanne, Heaton Will L, Joshi Deepa, Choi Henry, Eiring Anna, Batchelor Lance, Choudhry Priya, Manos Elizabeth J, Sofla Hossein, Sanati Ali, Welborn Seth, Agarwal Archana, Spangrude Gerald J, Miles Rodney R, Cox James E, Frazer J Kimble, Deininger Michael, Balan Kaveri, Sigman Matthew, Müschen Markus, Perova Tatiana, Johnson Radia, Montpellier Bertrand, Guidos Cynthia J, Jones David A, Trede Nikolaus S. Zebrafish screen identifies novel compound with selective toxicity against leukemia.. Blood. 2012. DOI: 10.1182/blood-2011-12-398818.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.